These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14575301)

  • 1. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R; Petrashevskaya N; Schwartz A; Aronow B; Boivin GP; Molkentin JD; Wieczorek DF
    Mol Cell Biochem; 2003 Sep; 251(1-2):33-42. PubMed ID: 14575301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
    J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
    Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
    Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways.
    Wernicke D; Thiel C; Duja-Isac CM; Essin KV; Spindler M; Nunez DJ; Plehm R; Wessel N; Hammes A; Edwards RJ; Lippoldt A; Zacharias U; Strömer H; Neubauer S; Davies MJ; Morano I; Thierfelder L
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R685-95. PubMed ID: 15031138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
    Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
    Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity.
    Stefanelli CB; Rosenthal A; Borisov AB; Ensing GJ; Russell MW
    Mol Genet Metab; 2004; 83(1-2):188-96. PubMed ID: 15464434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.
    Rajan S; Pena JR; Jegga AG; Aronow BJ; Wolska BM; Wieczorek DF
    Physiol Genomics; 2013 Sep; 45(17):764-73. PubMed ID: 23800848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
    Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy.
    Rajan S; Williams SS; Jagatheesan G; Ahmed RP; Fuller-Bicer G; Schwartz A; Aronow BJ; Wieczorek DF
    Physiol Genomics; 2006 Nov; 27(3):309-17. PubMed ID: 16882888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene.
    Gomes AV; Potter JD
    Mol Cell Biochem; 2004 Aug; 263(1-2):99-114. PubMed ID: 15524171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
    McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
    Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.
    Watkins H; McKenna WJ; Thierfelder L; Suk HJ; Anan R; O'Donoghue A; Spirito P; Matsumori A; Moravec CS; Seidman JG
    N Engl J Med; 1995 Apr; 332(16):1058-64. PubMed ID: 7898523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity.
    Jagatheesan G; Rajan S; Schulz EM; Ahmed RP; Petrashevskaya N; Schwartz A; Boivin GP; Arteaga GM; Wang T; Wang YG; Ashraf M; Liggett SB; Lorenz J; Solaro RJ; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H181-90. PubMed ID: 19429821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes.
    Michele DE; Albayya FP; Metzger JM
    Nat Med; 1999 Dec; 5(12):1413-7. PubMed ID: 10581085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.